SCHEMBL9493733

SCHEMBL9493733

CCOC(=O)CC(c1ccccc1)N1C(=O)c2cc(CCC(=O)NCCNC(=O)OC(C)(C)C)ccc2N(C)C(=O)C1c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
SCN9A Q15858 4/20 0.34
ITGB3 P05106 2/20 0.34
ITGA2B P08514 2/20 0.34
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
MDM2 Q00987 1/20 0.33
SIGMAR1 Q99720 2/20 0.33
CCKBR P32239 2/20 0.33
SLC6A9 P48067 1/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.32
HDAC3 O15379 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
HDAC4 P56524 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9493769 0.92 PDCD1 (0.37) PDCD1CD274SIGMAR1CYP3A4CYP2C19
SCHEMBL9494267 0.92 PDCD1 (0.36) PDCD1CD274SCN9ASIGMAR1CYP3A4
SCHEMBL9493013 0.92 PDCD1 (0.37) PDCD1CD274SCN9AMDM2SIGMAR1
SCHEMBL9493643 0.91 PDCD1 (0.35) PDCD1CD274MDM2SIGMAR1CYP3A4
SCHEMBL7318601 0.91 TPSAB1 (0.36) PDCD1CD274SCN9AITGB3ITGA2B
SCHEMBL7326332 0.89 ITGB3 (0.34) SCN9AITGB3ITGA2BF2F10
SCHEMBL7333235 0.85 SCN9A (0.38) SCN9AITGB3ITGA2BF2F10
SCHEMBL9262540 0.85 SCN9A (0.34) PDCD1CD274SCN9AITGB3ITGA2B
SCHEMBL9492960 0.84 PDCD1 (0.38) PDCD1CD274SIGMAR1SLC6A9CYP3A4
SCHEMBL7324643 0.83 PDCD1 (0.36) PDCD1CD274SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed